pubmed-article:20669965 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20669965 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:20669965 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
pubmed-article:20669965 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:20669965 | pubmed:dateCreated | 2010-8-19 | lld:pubmed |
pubmed-article:20669965 | pubmed:abstractText | In this study, we investigated the anticancer properties of methoxy-substituted nickel(II)(salophene) derivatives. We demonstrated that the most active complex [NiII(3-OMe-salophene)] is not necrotic in Burkitt-like lymphoma cells (BJAB) and human B-cell precursor cells (Nalm-6). [NiII(3-OMe-salophene)] inhibited proliferation and induced apoptosis in a concentration dependent manner, giving evidence for the involvement of CD95 receptor-mediated, extrinsic pathway. Furthermore, [NiII(3-OMe-salophene)] overcame vincristine drug resistance in BJAB and Nalm-6 cells. | lld:pubmed |
pubmed-article:20669965 | pubmed:language | eng | lld:pubmed |
pubmed-article:20669965 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20669965 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20669965 | pubmed:month | Aug | lld:pubmed |
pubmed-article:20669965 | pubmed:issn | 1520-4804 | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:LeeSoo-YoungS... | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:GustRonaldR | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:WölflStefanS | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:SchefflerHeik... | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:ProkopAramA | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:FriasCorazonC | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:HilleAnnegret... | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:KaterBenjamin... | lld:pubmed |
pubmed-article:20669965 | pubmed:author | pubmed-author:BonitzkiBirgi... | lld:pubmed |
pubmed-article:20669965 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20669965 | pubmed:day | 26 | lld:pubmed |
pubmed-article:20669965 | pubmed:volume | 53 | lld:pubmed |
pubmed-article:20669965 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20669965 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20669965 | pubmed:pagination | 6064-70 | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:meshHeading | pubmed-meshheading:20669965... | lld:pubmed |
pubmed-article:20669965 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20669965 | pubmed:articleTitle | [NiII(3-OMe-salophene)]: a potent agent with antitumor activity. | lld:pubmed |
pubmed-article:20669965 | pubmed:affiliation | Department of Pediatric Oncology/Hematology, University Medical Center Charite, Berlin, Germany. | lld:pubmed |
pubmed-article:20669965 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20669965 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |